Modèles transgéniques pour l'étude de la fonction ... - Epublications

Hauke, G., Epplen, J. T., Chluba, J., Hollmann, A. and Peter, H. H. (1988).
IgD/lambda plasmocytoma with immunoglobulin kappa light-chain genes in the germ-line
configuration. J Clin Immunol 8, 407-13.
Hecht, A. and Kemler, R. (2000). Curbing the nuclear activities of beta-catenin. Control
over Wnt target gene expression. EMBO Rep 1, 24-8.
Hertz, M. and Nemazee, D. (1997). BCR ligation induces receptor editing in IgM+IgD-
bone marrow B cells in vitro. Immunity 6, 429-36.
Hibbs, M. L., Tarlinton, D. M., Armes, J., Grail, D., Hodgson, G., Maglitto, R.,
Stacker, S. A. and Dunn, A. R. (1995). Multiple defects in the immune system of Lyn-deficient
mice, culminating in autoimmune disease. Cell 83, 301-11.
Hieter, P. A., Korsmeyer, S. J., Waldmann, T. A. and Leder, P. (1981). Human
immunoglobulin kappa light-chain genes are deleted or rearranged in lambda-producing B cells.
Nature 290, 368-72.
Hippen, K. L., Buhl, A. M., D'Ambrosio, D., Nakamura, K., Persin, C. and Cambier,
J. C. (1997). Fc gammaRIIB1 inhibition of BCR-mediated phosphoinositide hydrolysis and Ca2+
mobilization is integrated by CD19 dephosphorylation. Immunity 7, 49-58.
Hodoniczky, J., Zheng, Y. Z. and James, D. C. (2005). Control of recombinant
monoclonal antibody effector functions by Fc N-glycan remodeling in vitro. Biotechnol Prog 21,
1644-52.
Hoffmann, A., Kerr, S., Jellusova, J., Zhang, J., Weisel, F., Wellmann, U., Winkler,
T. H., Kneitz, B., Crocker, P. R. and Nitschke, L. (2007). Siglec-G is a B1 cell-inhibitory
receptor that controls expansion and calcium signaling of the B1 cell population. Nat Immunol 8,
695-704.
Hombach, J., Leclercq, L., Radbruch, A., Rajewsky, K. and Reth, M. (1988). A novel
34-kd protein co-isolated with the IgM molecule in surface IgM-expressing cells. Embo J 7,
3451-6.
Hombach, J., Lottspeich, F. and Reth, M. (1990). Identification of the genes encoding
the IgM-alpha and Ig-beta components of the IgM antigen receptor complex by amino-terminal
sequencing. Eur J Immunol 20, 2795-9.
Honjo, Y., Nangia-Makker, P., Inohara, H. and Raz, A. (2001). Down-regulation of
galectin-3 suppresses tumorigenicity of human breast carcinoma cells. Clin Cancer Res 7, 661-8.
Horikawa, K., Martin, S. W., Pogue, S. L., Silver, K., Peng, K., Takatsu, K. and
Goodnow, C. C. (2007). Enhancement and suppression of signaling by the conserved tail of IgG
memory-type B cell antigen receptors. J Exp Med 204, 759-69.
Hoyer, K. K., Pang, M., Gui, D., Shintaku, I. P., Kuwabara, I., Liu, F. T., Said, J. W.,
Baum, L. G. and Teitell, M. A. (2004). An anti-apoptotic role for galectin-3 in diffuse large Bcell
lymphomas. Am J Pathol 164, 893-902.
Hozumi, K., Negishi, N., Suzuki, D., Abe, N., Sotomaru, Y., Tamaoki, N., Mailhos,
C., Ish-Horowicz, D., Habu, S. and Owen, M. J. (2004). Delta-like 1 is necessary for the
generation of marginal zone B cells but not T cells in vivo. Nat Immunol 5, 638-44.
Huber, C., Huber, E., Lautner-Rieske, A., Schable, K. F. and Zachau, H. G. (1993).
The human immunoglobulin kappa locus. Characterization of the partially duplicated L regions.
Eur J Immunol 23, 2860-7.
Huelsken, J. and Birchmeier, W. (2001). New aspects of Wnt signaling pathways in
higher vertebrates. Curr Opin Genet Dev 11, 547-53.
Hughes, R. C. (1999). Secretion of the galectin family of mammalian carbohydratebinding
proteins. Biochim Biophys Acta 1473, 172-85.
161